These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 29208)

  • 21. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
    Clark BJ; Saameli K; Troxler F
    Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
    Giudicelli JF; Boissier JR
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the beta receptor blocking properties of two analogs of dichloroisoproterenol (DCI).
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):123-33. PubMed ID: 4146700
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of reserpine as well as alpha- and beta receptor blockaders on the lipid metabolism following endotoxin].
    Schmahl FW; Ohlemutz A; Huth K
    Verh Dtsch Ges Inn Med; 1969; 75():900-3. PubMed ID: 4396077
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative studies with the beta-receptor blockaders LB 46 and propranolol in healthy persons using the isoproterenol test].
    Bender F; Dotterweich K
    Med Welt; 1971 Sep; 22(37):1444-6. PubMed ID: 4398359
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological aspects of oxprenolol.
    Brunner H; Hedwall PR; Maier R; Meier M
    Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract]   [Full Text] [Related]  

  • 28. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 29. [Stereospecificity of beta-blocker effects on the glaucomatous eye].
    Krieglstein GK; Schrems W
    Fortschr Ophthalmol; 1984; 81(2):127-9. PubMed ID: 6145665
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors.
    Massingham R; Dubocovich ML; Shepperson NB; Langer SZ
    J Pharmacol Exp Ther; 1981 May; 217(2):467-74. PubMed ID: 6112260
    [No Abstract]   [Full Text] [Related]  

  • 32. The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis.
    Osborne NN; Wood JP
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3178-86. PubMed ID: 16799065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 34. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of reserpine and adrenergic alpha and beta blockaders on blood pressure effects of various sympathomimetics].
    Besson S; Barret F
    C R Seances Soc Biol Fil; 1970; 164(6):1309-11. PubMed ID: 4396769
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation between the potency of seven potential beta-adrenoceptor blocking drugs and propranolol to decrease heart rate in reserpinized rats and to perturb liposomes prepared from platelet lipids.
    Ondriasova E; Stasko A; Racanská E; Svec P; Ondrias K
    Pharmazie; 1991 Dec; 46(12):889-90. PubMed ID: 1687834
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of beta receptor blockaders in orthostatic dysregulation in a critical study and following long-term therapy].
    Weidinger P; Steinbach K
    Fortschr Med; 1973 Apr; 91(10):447-54. PubMed ID: 4144749
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blocking effect of puerarin on beta-adrenoceptors of isolated organs and the whole animal].
    Lu XR; Gao E; Xu LZ; Li HZ; Kang B; Chen WN; Chen SM; Chai XS
    Zhongguo Yao Li Xue Bao; 1986 Nov; 7(6):537-9. PubMed ID: 2886005
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of cardioselective beta adrenergic blockaders in the treatment of circulatory failure].
    Sterkowicz S
    Pol Tyg Lek; 1973 Jun; 28(26):987-90. PubMed ID: 4146971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.